A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
HLA class II α and β chains form receptors for antigen presentation to CD4(+) T cells. Numerous pairings of class II α and β subunits from the wide range of haplotypes and isotypes may form, but most of these combinations, in particular those produced by isotype mixing, yielded mismatched dimers. It is unclear how selection of functional receptors is achieved. At the atomic level, it is not known which interactions of class II residues regulate selection of matched αβ heterodimers and the evolutionary origin of matched isotype mixed dimer formation. In this study we investigated assembly of isotype-mixed HLA class II α and β heterodimers. Assembly and carbohydrate maturation of various HLA-class II isotype-mixed α and β subunits was dependent on the groove binding section of the invariant chain (Ii). By mutation of polymorphic DPβ sequences, we identified two motifs, Lys-69 and GGPM-(84-87), that are engaged in Ii-dependent assembly of DPβ with DRα. We identified five members of a family of DPβ chains containing Lys-69 and GGPM 84-87, which assemble with DRα. The Lys/GGPM motif is present in the DPβ sequence of the Neanderthal genome, and this ancient sequence is related to the human allele DPB1*0401. By site-directed mutagenesis, we inspected Neanderthal amino acid residues that differ from the DPB1*0401 allele and aimed to determine whether matched heterodimers are formed by assembly of DPβ mutants with DRα. Because the *0401 allele is rare in the sub-Saharan population but frequent in the European population, it may have arisen in modern humans by admixture with Neanderthals in Europe.
From the Section of Immunobiology, Institute of Genetics, University of Bonn, 53115 Bonn, Germany.
Sebastian
S
Temme
Martin
M
Zacharias
Jürgen
J
Neumann
Sebastian
S
Wohlfromm
Angelika
A
König
Nadine
N
Temme
Sebastian
S
Springer
John
J
Trowsdale
Norbert
N
Koch
D000595:Amino Acid Sequence; D000818:Animals; D000944:Antigens, Differentiation, B-Lymphocyte / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D001665:Binding Sites / Q000235:genetics; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D019143:Evolution, Molecular; D006682:HLA-DP Antigens / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D059867:HLA-DP alpha-Chains / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D059868:HLA-DP beta-Chains / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D006684:HLA-DR Antigens / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D059805:HLA-DR alpha-Chains / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D059806:HLA-DR beta-Chains / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D008958:Models, Molecular; D009154:Mutation; D059125:Neanderthals; D011485:Protein Binding; D055503:Protein Multimerization; D017434:Protein Structure, Tertiary
D000944:Antigens, Differentiation, B-Lymphocyte; D006682:HLA-DP Antigens; D059867:HLA-DP alpha-Chains; D059868:HLA-DP beta-Chains; C505113:HLA-DPB1*04:01 antigen; D006684:HLA-DR Antigens; D059805:HLA-DR alpha-Chains; D059806:HLA-DR beta-Chains; D000949:Histocompatibility Antigens Class II; C045084:invariant chain
Antigen Presentation; HLA Class II; Invariant Chain; Major Histocompatibility Complex (MHC); Protein Assembly; Protein Domains; Protein Evolution